A carregar...

Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks

BACKGROUND: Mechanisms underlying safety events may be heterogeneous and depend on conditions of development and marketing, including the populations studied in clinical trials and the amount of data required for approval, especially under pathways for accelerated access. OBJECTIVE: This study was c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceut Med
Main Authors: Fujikawa, Makoto, Ono, Shunsuke
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5629242/
https://ncbi.nlm.nih.gov/pubmed/29056852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40290-017-0198-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!